Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CME GroupCME +5.00%78 Debt-to-Equity is 0.13 as of Mar. 2026, which is at its 10-year median of 0.13. GuruFocus rates CME with a GF Score™ of 78/100 and a GF Value™ of $271.29 (Fairly Valued). The stock has 3 warning signs investors should review. Among 610 Capital Markets companies, CME Group ranks better than 67.7% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for CME Group's Debt-to-Equity or its related term are showing as below:
CME'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.1 Med: 0.13 Max: 0.17
Current: 0.13
During the past 13 years, the highest Debt-to-Equity Ratio of CME Group was 0.17. The lowest was 0.10. And the median was 0.13.
CME's Debt-to-Equity is ranked better than 67.7% of 610
companies
in the Capital Markets industry
Industry Median: 0.31
vs CME: 0.13
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
CME Group Debt-to-Equity Related Terms
CME Group Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for CME Group's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Financial Data & Stock Exchanges subindustry, CME Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group Debt-to-Equity vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where CME Group's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME Group (CME) has a Debt-to-Equity of 0.13 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on CME Group and its competitors. This is near median its historical median of 0.13. Over the past decade, CME Group's Debt-to-Equity has ranged from 0.10 to 0.17. According to the industry distribution chart, CME Group ranks #197 out of 610 companies in the Capital Markets industry, placing it in the top 32.3%.
Is CME Group's Debt-to-Equity too high?
CME Group's current Debt-to-Equity of 0.13 is near median its 10-year median of 0.13. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 0.17. The Capital Markets industry median Debt-to-Equity is 0.31. CME Group's value of 0.13 is 58.1% below this industry median. Based on the distribution chart, CME Group ranks #197 out of 610 companies in the Capital Markets industry, which is above the industry midpoint. Overall, CME Group has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CME Group's Debt-to-Equity compare to MCO and ICE?
According to the Capital Markets industry distribution chart, CME Group ranks #197 out of 610 companies for Debt-to-Equity. This puts CME Group in the upper half of its industry. The industry median Debt-to-Equity is 0.31. CME Group's value of 0.13 is 58.1% below this benchmark. Historically, CME Group's own Debt-to-Equity has ranged from 0.10 to 0.17 over the past decade. While the company's 10-year median is 0.13 vs. the industry median of 0.31, CME Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Capital Markets company?
The median Debt-to-Equity among Capital Markets companies is 0.31, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current Debt-to-Equity of 0.13 is 58.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on CME Group and its competitors. For the Capital Markets industry, the median Debt-to-Equity is 0.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current Debt-to-Equity is 0.13, which is near median its own 10-year median of 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Fairly Valued. The stock's GF Value™ is $271.29, compared to a current price of $249.24 — trading 8.1% below its estimated fair value. The current Debt-to-Equity is 0.13, which is near median its 10-year median of 0.13 and 58.1% below the Capital Markets industry median of 0.31. CME Group's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For CME Group (CME), the current Debt-to-Equity is 0.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of $249.24 is trading 8.1% below its estimated GF Value™ of $271.29.
GuruFocus considers CME Group to be Fairly Valued.
Key valuation signals for CME:
Debt-to-Equity: 0.13 (near median its 10-year median of 0.13)
GF Value™: $271.29 vs. price of $249.24 (8.1% below fair value)
Industry Position: 58.1% below the Capital Markets median (#197 of 610)
No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
78GF Score
Get the complete analysis for CME
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CME has been successfully added to your 
